Holy Basil For The Treatment Of Diabetes

Holy Basil for the Treatment of Diabetes

Ocimum sanctum, commonly referred to as holy basil, is an herb that is native to India; Ayurvedic medicine regards it as one of the most important plants. It is now widely grown throughout the world and can be eaten as a food or taken as a supplement. The leaves, stems, seeds and oils are all used medicinally.Many people with type 1 and type 2 diabetes use it to help lower high blood glucose levels.
Video of the Day
May Increase Insulin
Diabetes is a disorder characterized by chronic high blood glucose levels. There are two categories of diabetes. Type 1 individuals are unable to produce the hormone insulin and are therefore dependant on insulin injections. Type 2 diabetics make insulin but they either do not make enough, or they are insensitive to it. Some researchers theorize that holy basil can help to increase insulin secretion in type 2 diabetics, says Laura Shane-Mcwhorter in the book “The American Diabetes Association: Guide to Herbs and Nutritional Supplements.” Unfortunately there have not been enough rigorous studies to either confirm or disprove this theory.
Reducing Glucose Levels
Holy basil may also help to lower fasting and post-meal blood glucose levels. There was a study done on 40 type 2 diabetics, who were asked to stop all of their diabetes medications. Half of the patients were given 2.5 g of holy basil leaf powder daily, and the other half were given a placebo for four weeks. The groups were closely monitored and at the end of the study, holy basil was found to reduce fasting blood glucose levels by approximately 17.6 percent, and post-meal blood gl Continue reading

Rate this article

Total 1 ratings

BGR 34 for Diabetes

CSIR-NBRI (NATIONAL BOTANICAL RESEARCH INSTITUTE, LUCKNOW) and CSIR-CIMAP (CENTRAL INSTITUTE OF MEDICINAL & AROMATIC PLANTS, LUCKNOW), two laboratories of Council of Scientific and Industrial Research (CSIR) have jointly developed Antidiabetic ayurvedic medicines BGR 34. BGR 34 is now available in tablet form manufacturing license given to Aimil Pharmaceuticals Pvt. Ltd. Indian Government has recently approved BGR 34 medicine for diabetes. BGR 34 tablet contains aqueous extracts and powders of ayurvedic medicinal plants, already used for diabetes in ayurveda. Now, these extracts are combined and clinically approved efficacy in diabetes and blood sugar control.
Naming of BGR 34
BGR stands for:
B – Blood
G – Glucose
R – Regulator
34 indicate presence of 34 active constituents in BGR.
INGREDIENTS & COMPOSITION
The main ingredient of BGR-34 is Daruhaldi (Berberis Aristata), which acts as blood glucose regulator and stimulating insulin secretion.
EACH TABLET OF BGR 34 CONTAINS:
Dried Aqueous Extract Derived From:
Daruhaldi – Berberis Aristata
1150 mg
Vijaysar – Pterocarpus Marsupium
400 mg
Gudmar – Gymnema Sylvestre
400 mg
Manjistha – Rubia Cordifolia
375 mg
Methi (fenugreek) – Trigonella Foenum-Graecum
350 mg
Giloy – Tinospora Cordifolia
350 mg
Powders of:
Daruhaldi – Berberis Aristata
75 mg
Vijaysar – Pterocarpus Marsupium
25 mg
Gudmar – Gymnema Sylvestre
25 mg
Manjistha – Rubia Cordifolia
25 mg
Methi (fenugreek) – Trigonella Foenum-Graecum
25 mg
Giloy – Tinospora Cordifolia
25 mg
Solution Prepared From:
Shuddha Shilajit (Purified Black Bitumen)
1 Continue reading

Type 1 Diabetes: The Yoga Approach.

*Disclaimer: Elephant Journal articles represent the personal views of the authors, and can not possibly reflect Elephant Journal as a whole. Disagree with an Op-Ed or opinion? We’re happy to share your experience here. This website is not designed to, and should not be construed to, provide medical advice, professional diagnosis, opinion or treatment to you or any other individual, and is not intended as a substitute for medical or professional care and treatment.
~
I live with type 1 diabetes.
Flowers are pretty, girls are pretty, watching the sunset is pretty. But diabetes—not so much!
Picture this: It’s one in the morning and I’ve woken for the third time and checked my blood sugar, only to find that it’s low.
I take a nightly injection of insulin at nine p.m., and normally that shot will keep my blood sugar at a steady number until five a.m. However, I have LADA type 1 diabetes—Latent Autoimmune Diabetes in Adults—and sometimes my pancreas decides it’s not a useless organ sitting just underneath my ribcage. Instead, it’s a frisky puppy obsessed with a ball and it’s squirting insulin all over the place.
As I haul myself out of bed, don my slippers, and grab my computer, I prepare myself for the long night ahead, food all over the counter, fridge wide open, and way too much Instagram.
It’s during my midnight forays to treat a low blood sugar that I have to stop and remind myself that I haven’t always lived like this. I had a life before type 1 rocked my world.
I was diagnosed nine years ago, almost 25 years into my life. As a yogi and yoga teacher Continue reading

The Technology That Changes Lives For People With Diabetes - And Why I Think It Should Be Available On The NHS

Most people assume the worst thing about living with type one diabetes is having to inject insulin four times a day. I'm not going to lie, that isn't fun. But for me, without doubt, the most frustrating aspect of daily life with a defective pancreas is testing my blood sugar.
Firing a tiny needle into my finger to draw blood multiple times a day doesn't just hurt - it's not the easiest thing to do quickly and discreetly in the midst of a busy life. This means that, although I know good blood sugar control is important for both my long and short-term health, I probably don't do it as often as I should.
When I was diagnosed, I was given a glucose meter and finger-pricker, prescribed lancets and testing strips and told to check my blood sugar before meals, before driving, before bed, when I think my blood sugar is too high, too low, when I'm ill, when I'm exercising...
On some days, this can mean testing ten times or more - each time, stabbing my finger, squeezing some blood onto a testing strip and then waiting for the meter to reveal my blood sugar level.
In the UK, this is currently the only method of blood glucose testing available free of charge on the NHS. But for those who can afford £1,200+ a year, there is a far easier way of doing it.
Flash monitoring is a new technology - a small sensor that you wear under your skin. It stores your blood glucose levels continuously and you can access your readings whenever you want by scanning the sensor with your glucose meter (or even your mobile phone).
While it doesn't entirely take away the need for finger-pricking, it minimis Continue reading

Festus teenager at the forefront of breakthrough in diabetes care

Audrey McKinney is at the forefront of a major development in technology for managing diabetes, one that many Type 1 diabetics have long waited for.
She’s the first pediatric patient in St. Louis to use what some consider an artificial pancreas made by Medtronic.
The device is able to automatically adjust the rate of insulin pumped into the body by responding to blood sugar levels measured by a separate sensor.
While insulin pumps are not new, the Medtronic MiniMed 670G is able to act on its own — to an extent — relieving some of the decision-making burden for diabetics.
“I think the pump is an amazing advancement in the technology. It’s helped me out so much and it makes me feel like I’ve never been sick,” McKinney, 17, of Festus, said.
Her health has improved as a result of the new technology, according to her pediatric endocrinologist, Dr. Susan Myers of Cardinal Glennon.
She now spends 72 percent of the time in a healthy blood sugar range. That’s an improvement from 50 percent of the time when she was using a pump without the advanced technology, Myers said.
The overall health of a diabetic patient is greatly improved when blood sugar levels are tightly controlled; when they’re not it can lead to long-term complications and stress on other organs.
Many patients were so eager for this type of technology that they began to hack their own insulin pumps to automate them in this way.
Some credit these do-it-yourself patients for helping push Medtronic and the FDA to speed up the process of getting the current device to market.
They were part of the #WeAreNo Continue reading